James E. Flynn - Sep 30, 2025 SCHEDULE 13G/A Report for Lomond Therapeutics Holdings, Inc. Common Stock

Filing Manager
Flynn James E
Reporting Manager
Deerfield Mgmt, L.P.
Security
Lomond Therapeutics Holdings, Inc. Common Stock
Shares outstanding
32.2M shares
Disclosed Ownership
2.69M shares
Ownership
8.36%
Form type
SCHEDULE 13G/A
Date filed
11/13/2025, 04:28 PM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 8.36% 2.69M 0 2.69M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 8.36% 2.69M 0 2.69M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 8.36% 2.69M 0 2.69M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 8.36% 2.69M 0 2.69M /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact